NEW YORK (GenomeWeb News) – Illumina has expanded the scope of its multi-year genotyping services agreement with GlaxoSmithKline, Illumina said today.
 
Under the new agreement, Illumina will use its Sentrix HumanHap550 BeadChips for a series of whole-genome association studies.
 
As the first study, Illumina will genotype a collection of 2,000 case and control DNA samples provided by GSK for an undisclosed disease.
 
Financial details were not disclosed.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

An Australian-led team has generated a draft genome assembly of the invasive cane toad in hopes it will help in population control, the Sydney Morning Herald reports.

The New York Times reports that the US Department of Defense has implemented about half the recommendations made to improve safe handling of dangerous agents.

In PLOS this week: approach for teasing out archaic introgression in human genomes, immune transcription features in HCV infection, and more.

Stat News reports that Maryland is promoting itself to the biotech industry with a mobile billboard.

Oct
17
Sponsored by
Lexogen

This webinar will present a method for RNA-seq expression analysis of FFPE-derived RNA samples that are too degraded for successful application of standard RNA-seq techniques.

Oct
25
Sponsored by
Roche

This webinar will detail a comprehensive strategy that a lab has put in place to evaluate  NGS oncology assays for genomic tumor profiling of plasma and tissue samples.